Navigation Links
NephRx Corp. Awarded U.S. Patent for Use of Novel Growth Factor Peptide NX002 in Inflammatory Bowel Disease
Date:3/23/2011

KALAMAZOO, Mich., March 23, 2011 /PRNewswire/ -- NephRx Corporation today announced issuance of a new U.S. patent for use of its novel growth factor peptide NX002 as a potential treatment for inflammatory bowel disease (IBD).  Animal studies suggest that NX002 may have applications in acute and chronic diseases of the gastrointestinal tract, including Crohn’s disease and ulcerative colitis.  It has been shown to stimulate the growth of epithelial cells and to promote mucosal wound healing after injury.  NX002 is currently in preclinical studies for the treatment of IBD and in late preclinical development as a potential treatment for oral mucositis.

“Issuance of this new patent is important given the promising utility of NX002 as a potential treatment for serious disorders of the gastrointestinal system,” said James Koziarz, President and CEO of NephRx.  “We have been encouraged by the efficacy demonstrated by NX002 in models of oral mucositis, and early studies suggest its distinctive mechanism of action also has potential as a novel treatment for inflammatory bowel disease.  This family of painful and disabling conditions affects more than a million patients in the U.S. alone, and despite recent advances, many remain poorly treated.”

NX002 is a peptide derived from the naturally occurring growth factor AMP-18.  Its multiple biological properties include the ability to protect cells from injury, stimulate cell growth and migration, and increase the accumulation of proteins that bind cells together.

The U.S. Patent and Trademark Office issued Patent No. 7910543, “Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors.”  Rights to this patent, which protects NX002 and related compounds, have been exclusively licensed to NephRx by the University of Chicago.

About Inflammatory Bowel DiseaseInflammatory bowel disease (IBD) refers
'/>"/>

SOURCE NephRx Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. NephRx Corp. Awarded New U.S. Patent for Oral Mucositis Agent NX002
2. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
3. Cantel Medical Corp.s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products
4. Alliance Pharmaceutical Corp. Updates Oxygent(TM) Clinical Development Plan
5. Raptor Pharmaceuticals Corp. Initiates Phase IIa Clinical Study for Convivia(TM)
6. Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting
7. BioSpecifics Technologies Corp. Announces Initiation of Phase IIb Trial for Peyronies Disease
8. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
9. BioSpecifics Technologies Corp. to Present at Cowen and Company 29th Annual Health Care Conference
10. BioSpecifics Technologies Corp. Announces XIAFLEX(TM) CORD I Study Published in New England Journal of Medicine
11. Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... CAMBRIDGE, Mass. and HERZLIYA-PITUACH, Israel ... and NASDAQ OMX First North Premier, Stockholm ... received confirmation that its application to list its common stock ... NASDAQ Stock Market, a unit of the NASDAQ OMX Group. ... NASDAQ Capital Market at the opening of trading on August ...
(Date:8/18/2014)... , Aug. 18, 2014 Reportlinker.com ... is available in its catalogue: ... http://www.reportlinker.com/p01597713/Bioseparation-Systems-for-Global-Biopharmaceutical-Markets.html ... into three types: chromatography, membranes/filters and centrifuges. ... increasing and fueling growth of the global ...
(Date:8/18/2014)... Reportlinker.com announces that a new market ... Russia Bariatric Surgery Devices Market ... Russia Bariatric Surgery Devices Market ... GlobalData,s new report, "Russia Bariatric Surgery Devices ... on the Russia Bariatric Surgery Devices market. The ...
Breaking Medicine Technology:Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 2Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 3Immune Pharmaceuticals Announces Approval for Listing on the NASDAQ Capital Market 4Bioseparation Systems for Global Biopharmaceutical Markets 2Bioseparation Systems for Global Biopharmaceutical Markets 3Bioseparation Systems for Global Biopharmaceutical Markets 4Bioseparation Systems for Global Biopharmaceutical Markets 5Bioseparation Systems for Global Biopharmaceutical Markets 6Bioseparation Systems for Global Biopharmaceutical Markets 7Bioseparation Systems for Global Biopharmaceutical Markets 8Bioseparation Systems for Global Biopharmaceutical Markets 9Bioseparation Systems for Global Biopharmaceutical Markets 10Bioseparation Systems for Global Biopharmaceutical Markets 11Bioseparation Systems for Global Biopharmaceutical Markets 12Russia Bariatric Surgery Devices Market Outlook to 2020 2Russia Bariatric Surgery Devices Market Outlook to 2020 3Russia Bariatric Surgery Devices Market Outlook to 2020 4Russia Bariatric Surgery Devices Market Outlook to 2020 5
(Date:8/20/2014)... (PRWEB) August 20, 2014 Blaine ... the innovative RevitaDERM® Psoriasis Treatment to ... associated with psoriasis. This all-in-one product was created ... RevitaDERM® Psoriasis Treatment is powered by coal tar ... associated with this effective ingredient. , RevitaDERM® ...
(Date:8/20/2014)... August 20, 2014 First Choice ... emergency rooms in the United States, named Richard Daniels, ... FM 685 facility. , “We are pleased to ... director of our second facility in Pflugerville,” said Dr. ... Emergency Room. , Dr. Daniels received his undergraduate ...
(Date:8/20/2014)... What to Do Now for UDI:, ... the Market, **FDAnews Webinar**, Sept. 11, 2014 — 1:30 ... Hospitals and other buyers of devices lose $5 billion ... systems. , Complying with the FDA’s deadlines is important, ... UDI as soon as possible. If devicemakers don’t, ...
(Date:8/19/2014)... Vancouver, WA (PRWEB) August 20, 2014 As ... school, and for themselves to return to the normal routine ... and snacks in tow, Kristen Yarker, MSc, RD encourages ... standard for their kids’ snack time. , Yarker explains, ... need for nutrients. Instead of giving them junk food handouts, ...
(Date:8/19/2014)... (PRWEB) August 20, 2014 What gives skin ... What can soften skin, replenish and nourish it while lightly ... Beauty®. , "Client after client raves about how their skin ... Heshelow, founder of Sublime Beauty®. "The ingredients are very ... use. Simply smooth it over cleansed skin of the ...
Breaking Medicine News(10 mins):Health News:RevitaDERM® Psoriasis Treatment Now Available At Over 7,600 CVS/pharmacies 2Health News:First Choice Emergency Room Announces Dr. Richard Daniels as Medical Director of the Pflugerville – FM 685 Facility 2Health News:FDAnews Announces — What to Do Now for UDI: Don’t Lose Your Customers by Getting Locked Out of the Market Webinar, Sept. 9, 2014 2Health News:FDAnews Announces — What to Do Now for UDI: Don’t Lose Your Customers by Getting Locked Out of the Market Webinar, Sept. 9, 2014 3Health News:FDAnews Announces — What to Do Now for UDI: Don’t Lose Your Customers by Getting Locked Out of the Market Webinar, Sept. 9, 2014 4Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 2Health News:Child Nutritionist Kristen Yarker Wants Parents to Rethink Kids’ Snacks This Fall 3Health News:That "Something Special" to Improve Skin Takes Only 10 Minutes Per Week; on Sale at Sublime Beauty® 2
... The cost of low health literacy the difference ... abilities to effectively communicate complex medical information is ... a leading biopharmaceutical company. To improve the health literacy ... offer a health literacy study emphasis beginning this fall. ...
... , ... Government Agencies to Increase ROI of IT Infrastructure , ... Reston, VA (PRWEB) February 18, 2010 -- Carahsoft ... Parabonâ Computation , a veteran provider of extreme-scale grid computing software and services. ...
... ... completed system-wide implementation of a software standardization program at seven hospital laboratories of ... ... , a leading provider of healthcare diagnostic information technology and outreach solutions, has ...
... rare thyroid tumor, but experts say effects in humans ... The U.S. Food and Drug Administration is defending its ... drug, Victoza (liraglutide), even though animal studies suggest it ... , Victoza, among a class of medicines called glucagon-like ...
... 2010) Van Andel Research Institute (VARI) researchers ... treatment that is currently the first line of defense against ... kidney cancer. Most patients who show a positive response ... year of treatment. Kidney cancer is among the 10 ...
... , ST. PETERS, Mo. , Feb. 18 ... Inc., has donated $25,000 to Meds & Food for ... to saving the lives of Haiti ,s malnourished children and ... peanut-based ready-to-use therapeutic food (RUTF) – known in Haiti ...
Cached Medicine News:Health News:MU offers training program to improve health literacy 2Health News:Parabon's Frontier Grid Platform Software Now Available on Carahsoft's GSA Schedule 2Health News:Parabon's Frontier Grid Platform Software Now Available on Carahsoft's GSA Schedule 3Health News:Sunquest Completes System-Wide Implementation at Cleveland Clinic Hospital Laboratories 2Health News:FDA Approved Diabetes Drug Despite Hints at Cancer Risk 2Health News:FDA Approved Diabetes Drug Despite Hints at Cancer Risk 3Health News:VARI findings may help patients with deadly kidney cancer 2Health News:MEMC Foundation Donates to Help Fight Malnourishment in Haiti 2Health News:MEMC Foundation Donates to Help Fight Malnourishment in Haiti 3
... Cruise Control is ... STAAR as a filter ... and aspiration tubing that ... the safety and efficiency ...
... The robust, compact Sleepscan Traveler provides the ... can acquire PSG data in the home, ... laboratory. Traveler sleep studies utilize the same ... in-lab studies. Sleepscan Traveler studies take full ...
... Pioneer in Digital EEG ,The company ... system presents the latest addition to ... VISION. This innovative system incorporates the ... and information management to offer you ...
"Ganzfeld" stimulations for flash VEP, flash ERG and sensory EOG. Complies with international standards of electrophysiology....
Medicine Products: